Unimedic AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Unimedic AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10929
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unimedic AB (Unimedic), formerly Ergobe Pharma AB, a subsidiary of MedCap AB, is a pharmaceutical company which develops, manufactures, distributes and markets pharmaceutical products. The company offers non-licensed, extemporaneous, and licensed pharmaceuticals targeting the therapy areas which include anesthesiology or intensive care, gastroenterology, immunoglobulins or transplant, and drug addiction treatment. It also provides services including contract development, validation, chemical and microbiological analyses of active raw materials (API), excipients, water for injection (WFI) and finished products; performs stability studies; and formulation development from laboratory scale batches up to full scale batches. Unimedic also supplies imported pharmaceuticals to pharmacies; and provides repackaging services for medical products, dietary supplements, cosmetics or medical devices, and clinical trials. The company partners with academics, industry and the health care sectors. Unimedic is headquartered in Matfors, Sweden.

Unimedic AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unimedic AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Unimedic AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unimedic AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Unimedic Enters into Distribution Agreement with Mylan 10
Licensing Agreements 11
Unimedic Pharma Enters into Licensing Agreement with Basilea Pharma 11
Unimedic Enters into Licensing Agreement with Martindale Pharma 12
Acquisition 13
Unimedic Acquires Miwana 13
Unimedic Acquires Cross Pharma From Medivir For USD18.6 Million 14
Unimedic Acquires Pharmadone 15
Unimedic Acquires Ergobe Pharma 16
Unimedic AB – Key Competitors 17
Unimedic AB – Key Employees 18
Unimedic AB – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Unimedic AB, Pharmaceuticals & Healthcare, Key Facts 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unimedic AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unimedic AB, Deals By Therapy Area, 2012 to YTD 2018 8
Unimedic AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unimedic Enters into Distribution Agreement with Mylan 10
Unimedic Pharma Enters into Licensing Agreement with Basilea Pharma 11
Unimedic Enters into Licensing Agreement with Martindale Pharma 12
Unimedic Acquires Miwana 13
Unimedic Acquires Cross Pharma From Medivir For USD18.6 Million 14
Unimedic Acquires Pharmadone 15
Unimedic Acquires Ergobe Pharma 16
Unimedic AB, Key Competitors 17
Unimedic AB, Key Employees 18
Unimedic AB, Subsidiaries 19

List of Figures
Unimedic AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unimedic AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unimedic AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Unimedic AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • T7 Global Berhad (T7GLOBAL):石油・ガス:M&Aディール及び事業提携情報
    Summary T7 Global Berhad (T7 Global), formerly Tanjung Offshore Berhad, is an oil and gas company that offers gas generators and integrated services. The company's services include topside maintenance, engineering and procurement, installation and commissioning, initial engineering design layout, pr …
  • Waste Management Inc (WM):電力:M&Aディール及び事業提携情報
    Summary Waste Management Inc (WM) is a provider of waste management environmental services. The company has presence in the waste management vertical from collection, solid and hazardous waste landfills management, transfer, recycling and resource recovery, to disposal. Through its personal counseli …
  • OBJ Ltd (OBJ):医療機器:M&Aディール及び事業提携情報
    Summary OBJ Ltd (OBJ) is a developer of magnetic micro-array drug and ingredient delivery technologies. The company offers services such as drug or ingredient profiling in skin, laboratory facilities and capabilities, formulation development, product development, product optimisation, and pre-commer …
  • Perrigo Company plc:企業の戦略・SWOT・財務分析
    Perrigo Company plc - Strategy, SWOT and Corporate Finance Report Summary Perrigo Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Royal Dutch Shell Plc (RDSA):企業の財務・戦略的SWOT分析
    Royal Dutch Shell Plc (RDSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Entravision Communications Corp (EVC):企業の財務・戦略的SWOT分析
    Entravision Communications Corp (EVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Syniverse Holdings Inc:企業の戦略的SWOT分析
    Syniverse Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • DIC Corp (4631):企業の財務・戦略的SWOT分析
    DIC Corp (4631) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Ishida Co., Ltd.:企業の戦略・SWOT・財務情報
    Ishida Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ishida Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kyushu Financial Group Inc (7180):企業の財務・戦略的SWOT分析
    Kyushu Financial Group Inc (7180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Grupo Farma:企業の戦略的SWOT分析
    Grupo Farma - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • B&N Bank (Joint-Stock Company):企業の戦略・SWOT・財務情報
    B&N Bank (Joint-Stock Company) - Strategy, SWOT and Corporate Finance Report Summary B&N Bank (Joint-Stock Company) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Drive Shack Inc:企業のM&A・事業提携・投資動向
    Drive Shack Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Drive Shack Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Malaysian Pacific Industries Berhad (MPI):企業の財務・戦略的SWOT分析
    Malaysian Pacific Industries Berhad (MPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Amryt Pharma plc (AMYT):製薬・医療:M&Aディール及び事業提携情報
    Summary Amryt Pharma plc (Amryt) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for patients with rare and orphan diseases. It has two marketed products include Lojuxta for the treatment of adult HoFH and Episalvan for the treatment of PTW. The …
  • Epic Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Epic Pharma LLC (Epic Pharma), a subsidiary of Humanwell Healthcare (Group) Co Ltd is a drug development company that manufactures and develops generic prescription drugs. The company’s products include amlodipine besylate, citalopram, betaxolol, nicardipine hydrochloride, guanfacine hydroch …
  • Marquard & Bahls AG:企業の戦略的SWOT分析
    Marquard & Bahls AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • First Solar Inc (FSLR):企業の財務・戦略的SWOT分析
    First Solar Inc (FSLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • I Grandi Viaggi Spa:企業の戦略・SWOT・財務分析
    I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report Summary I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Yanchang Petroleum International Ltd (346):企業の財務・戦略的SWOT分析
    Yanchang Petroleum International Ltd (346) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆